Five years ago, large numbers of farmers in central China began falling victim to an mysterious disease marked by high fever, gastrointestinal disorder and an appalling mortality rate — as high as 30 percent in initial reports.
Changes that occur in the airways of asthma patients are in part caused by the naturally occurring protein interleukin-13 which stimulates invasion of airway cells called fibroblasts.
According to a new study, patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation.
Researchers have discovered a novel mechanism in gene regulation that contributes to the development of a form of liver cancer called hepatocellular carcinoma. This breakthrough identifies a promising new target for therapeutic intervention.
Preclinical Oncology Services Limited, a leading pre-clinical research and development service provider, has extended its alliance with Argenta to continue providing comprehensive oncology-focused drug discovery services.
Seattle Genetics, Inc. has formed a collaboration with Abbott under which Abbott will pay an upfront fee of $8 million for rights to utilize Seattle Genetics’ antibody-drug conjugate (ADC) technology with antibodies to a single oncology target.
Food and Drug Administration assigns Prescription Drug User Fee Act date for the review of the FIRAZYR NDA for the treatment of acute attacks of hereditary angioedema.
NephRx Corporation announced the issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
Pozen Inc. announced a deal with Johnson & Johnson's Cilag GmbH International division to make and sell its migraine drug in South America. Pozen said Cilag will sell its drug, MT 400, in Brazil, Colombia, Ecuador and Peru.
OMS302 is Omeros' pharmacosurgery product in development to maintain intra-operative mydriasis (pupil dilation) and reduce postoperative pain and irritation resulting from cataract and other lens replacement surgery.
Hi-Tech Pharmacal Co., Inc. announced that the U.S. Food and Drug Administration, granted final approval for its Abbreviated New Drug Application, for ranitidine syrup 15mg/mL, the generic for GlaxoSmithKline's Zantac syrup.
The RingDex is a filling system with a unique modular design that will greatly improve previously manual & tedious filling / capping operations. Unlike traditional filling systems, the RingDex allows quick changeovers for low to medium volume production.
The INTEGRA VIAFLO 96 is a 96-channel electronic pipette that enables fast, precise and easy simultaneous transfer of 96 samples. The VIAFLO 96 has been designed to be used just like a standard handheld pipette.
Supercritical Fluid Technologies introduces a benchtop supercritical fluid extractor, the SFT-110XW. The completely redesigned restrictor valve with integrated micrometer allows for very precise flow control, which is essential for demanding applications.